Chong Kun Dang Pharmaceutical Corp. (185750.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

8.5x

Market Cap

KRW 941.36B

MomentumView details →

1D Return

−1.59%

YTD Return

−17.97%

RSI (14)

48.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

8.5x

Market Cap

KRW 941.36B

RSI (14)

48.5

MomentumView details →

1D Return

−1.59%

YTD Return

−17.97%

ProfitabilityView details →

Gross Margin

29.03%

Net Margin

4.46%

EBITDA Margin

6.95%

ROE (TTM)

7.83%

ROA (TTM)

4.26%

Asset Turnover

0.96x

GrowthView details →

Revenue YoY

+7.14%

EPS YoY

+25.96%

FCF YoY

−27.78%

Revenue CAGR 3Y

+4.38%

EPS CAGR 3Y

−3.81%

EBITDA YoY

−42.84%

EarningsView details →

EPS (Actual)

KRW 1,302.71

EPS Surprise

−48.79%

Beats (12Q)

0/12

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

−48.79%

Rev Surprise

0.03%

Capital & dividendView details →

Debt/Equity

0.43x

Current Ratio

2.04x

Quick Ratio

1.25x

Div Yield

0.73%

Div Rate

KRW 500.00

Div Growth 1Y

−54.55%

Financials snapshotView financials →

Revenue (TTM)

1.78T

Net Income (TTM)

79.47B

Op. CF (TTM)

123.26B

Latest newsMore news →

No recent news for 185750.KS.

Similar companies

DongKook Pharmaceutical Co., Ltd.086450.KQ Shinpoong Pharmaceutical Co.,Ltd019175.KS Humedix Co., Ltd.200670.KQ Boryung Corporation003850.KS JW Pharmaceutical Corporation001067.KS Daewoong pharmaceutical Co.,Ltd069620.KS Find similar companies →

Latest newsMore news →

No recent news for 185750.KS.